These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 14632794)

  • 21. [From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A].
    Reitsma PH; van de Stolpe A
    Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1843-5. PubMed ID: 11593787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Oral contraceptives and activated protein C resistance: a paradigmatic example of genotype and environment interaction in the development of deep venous thrombosis].
    Panzini E; Raffa S; Miconi R; Lozzi A; Marci M
    Clin Ter; 1999; 150(6):445-7. PubMed ID: 10756665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor V Leiden paradox: risk of deep-vein thrombosis but not of pulmonary embolism.
    Bounameaux H
    Lancet; 2000 Jul; 356(9225):182-3. PubMed ID: 10963193
    [No Abstract]   [Full Text] [Related]  

  • 24. Heterogeneity of activated protein C resistance phenotype in subjects with compound heterozygosity for HR2 haplotype and FV Leiden mutation (R506Q) in factor V gene.
    Castaman G; Ruggeri M; Tosetto A; Rodeghiero F
    Thromb Haemost; 2000 Aug; 84(2):357-8. PubMed ID: 10959717
    [No Abstract]   [Full Text] [Related]  

  • 25. Factor V Leiden and the common haemochromatosis mutation HFE C282Y: is there an association in familial venous thromboembolic disease?
    MacLean RM; Feeney GP; Bowley SJ; Bowen DJ; Worwood M; Collins PW
    Br J Haematol; 1999 Oct; 107(1):210-2. PubMed ID: 10520044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Activated protein C resistance of an acquired nature: the potential role of hormonal treatment and of elevated factor VIII plasma levels].
    Iturbe Hernández T; Varo MJ; Olave MT; Fuertes MA; Cornudella R
    Rev Clin Esp; 1999 Sep; 199(9):618. PubMed ID: 10568160
    [No Abstract]   [Full Text] [Related]  

  • 27. The factor V R2 allele: risk of venous thromboembolism, factor V levels and resistance to activated protein C.
    Luddington R; Jackson A; Pannerselvam S; Brown K; Baglin T
    Thromb Haemost; 2000 Feb; 83(2):204-8. PubMed ID: 10739373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to activated protein C in women using oral contraceptives.
    Spannagl M; Dick A; Assmann A; Heinemann L; Schramm W
    Semin Thromb Hemost; 1998; 24(5):423-30. PubMed ID: 9834008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APC resistance, oral contraceptive therapy and deep vein thrombosis: settled and unsettled problems.
    Girolami A; Simioni P; Tormene D
    Haematologica; 2000 Mar; 85(3):225-6. PubMed ID: 10702806
    [No Abstract]   [Full Text] [Related]  

  • 30. Further evidence that activated protein C resistance affects protein C coagulant activity assays.
    Jennings I; Kitchen S; Cooper PC; Rimmer JE; Woods TA; Preston FE
    Thromb Haemost; 2000 Jan; 83(1):171-2. PubMed ID: 10669173
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of factor V Leiden carriage on maternal and fetal health.
    Bloomenthal D; von Dadelszen P; Liston R; Magee L; Tsang P
    CMAJ; 2002 Jul; 167(1):48-54. PubMed ID: 12137081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factor V Leiden in patients with venous thrombosis in Slovak population.
    Simkova M; Batorova A; Dostalova K; Pozgayova S; Simko F; Kovacs L
    Gen Physiol Biophys; 2004 Dec; 23(4):435-42. PubMed ID: 15815078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudohomozygosity for activated protein C resistance is a risk factor for venous thrombosis.
    Castaman G; Tosetto A; Ruggeri M; Rodeghiero F
    Br J Haematol; 1999 Jul; 106(1):232-6. PubMed ID: 10444192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden.
    Graf LL; Welsh CH; Qamar Z; Marlar RA
    Am J Clin Pathol; 2003 Jan; 119(1):52-60. PubMed ID: 12520697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma homocysteine and hematological factors in patients with venous thromboembolic diseases in Kuwait.
    Marouf R; Mojiminiyi O; Qurtom M; Abdella N; Al Wazzan H; Al Humood S; Al Mazeedy M
    Acta Haematol; 2007; 117(2):98-105. PubMed ID: 17135722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between sensitivity for activated protein C (APC) and lipid or lipoprotein levels.
    González-Ordóñez AJ; Venta R; Terrados N; Arias A; Macías-Robles MD
    Thromb Haemost; 2002 Dec; 88(6):1069-71. PubMed ID: 12529764
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral contraceptive pills and inherited thrombophilia in a young woman with deep venous thrombosis.
    Mahfouz RA; Otrock ZK; Ghasham MA; Sabbagh AS; Taher AT; Bazarbachi A
    East Mediterr Health J; 2009; 15(1):235-8. PubMed ID: 19469449
    [No Abstract]   [Full Text] [Related]  

  • 38. Venous thromboembolic disease: risk factors and laboratory investigation.
    Alhenc-Gelas M; Aiach M; de Moerloose P
    Semin Vasc Med; 2001; 1(1):81-8. PubMed ID: 15199517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inherited and acquired thrombophilic alterations in patients with superficial vein thrombosis of lower limbs.
    Legnani C; Cini M; Cosmi B; Filippini M; Favaretto E; Palareti G
    Thromb Haemost; 2014 Jun; 111(6):1194-6. PubMed ID: 24500135
    [No Abstract]   [Full Text] [Related]  

  • 40. Sudden hearing loss followed by deep vein thrombosis and pulmonary embolism in a patient with factor V Leiden mutation.
    Lovato A; Tormene D; Staffieri C; Breda S; Staffieri A; Marioni G
    Int J Audiol; 2014 Sep; 53(9):625-8. PubMed ID: 24735015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.